CS logo
small CS logo
Rochester Clinical Research, Inc.

Rochester, New York, United States
Medical center in Irondequoit, New York
500 Helendale Rd, Rochester, NY 14609

About Rochester Clinical Research, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
25
Eli Lilly and Company
13
ModernaTX, Inc.
6
BioNTech SE
5
Emergent BioSolutions
5
Janssen Vaccines & Prevention B.V.
5
Allergan
4
AstraZeneca
4
Achieve Life Sciences
3
Bavarian Nordic
3
Biomedical Advanced Research and Development Authority
3
Total Rows: 73

Clinical Trials at Rochester Clinical Research, Inc.


During the past decade, Rochester Clinical Research, Inc. conducted 93 clinical trials. In the 10-year time frame, 93 clinical trials started and 71 clinical trials were completed, i.e. on average, 76.3% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 42 clinical trials were completed. i.e. 95.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44881515111111111111161617175533337711111616141466Started TrialsCompleted Trails2015201620172018201920202021202205101520
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Muscle Strengthening Device for Knee Osteoarthritis
2001-09-01
2002-07-01
Completed
92
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
2002-05-01
2003-08-01
Completed
734
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
2002-03-01
2003-06-01
Completed
336
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
2003-09-01
2004-01-01
Completed
99
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
2000-04-27
2003-11-07
Completed
2,532
Open Label Extension Study of PREOS
2001-10-16
2005-04-13
Completed
1,683
Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
2005-04-01
2005-12-01
Completed
1,800
The Effect of Betahistine on Body Weight in Obese Subjects
2007-01-01
2007-06-01
Completed
280

Rows per page:

1–100 of 159

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rochester Clinical Research, Inc." #1 sponsor was "Pfizer" with 25 trials, followed by "Eli Lilly and Company" with 13 trials sponsored, "ModernaTX, Inc." with 6 trials sponsored, "BioNTech SE" with 5 trials sponsored and "Emergent BioSolutions" with 5 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 73 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Clinical Research, Inc." #1 collaborator was "Pfizer" with 5 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator and "Allergan Sales, LLC" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 25Pfizer: 25Eli Lilly and Company: 13Eli Lilly and Company: 13ModernaTX, Inc.: 6ModernaTX, Inc.: 6BioNTech SE: 5BioNTech SE: 5Emergent BioSolutions: 5Emergent BioSolutions: 5Janssen Vaccines &Prevention B.V.: 5Janssen Vaccines &Prevention B.V.: 5Allergan: 4Allergan: 4AstraZeneca: 4AstraZeneca: 4Achieve Life Sciences: 3Achieve Life Sciences: 3Bavarian Nordic: 3Bavarian Nordic: 3

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 5Pfizer: 5Biomedical AdvancedResearch andDevelopment Authority:2Biomedical AdvancedResearch andDevelopment Authority:2CoLucid Pharmaceuticals: 2CoLucid Pharmaceuticals: 2Department of Healthand Human Services: 2Department of Healthand Human Services: 2Allergan Sales, LLC: 1Allergan Sales, LLC: 1Baker Heart andDiabetes Institute: 1Baker Heart andDiabetes Institute: 1Catalyst ClinicalResearch, LLC: 1Catalyst ClinicalResearch, LLC: 1Chiltern International Inc.: 1Chiltern International Inc.: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Institut de RecherchesInternationales Servier:1Institut de RecherchesInternationales Servier:1

Clinical Trials Conditions at Rochester Clinical Research, Inc.


According to Clinical.Site data, the most researched conditions in "Rochester Clinical Research, Inc." are "Migraine" (14 trials), "Influenza" (11 trials), "Obesity" (6 trials), "COVID-19" (5 trials) and "Herpes Labialis" (5 trials). Many other conditions were trialed in "Rochester Clinical Research, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Rochester Clinical Research, Inc.


Most popular intervention types in "Rochester Clinical Research, Inc." are "Drug" (82 trials), "Biological" (71 trials), "Other" (18 trials), "Device" (8 trials) and "Behavioral" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (70 trials), "Rimegepant" (5 trials), "Ad26.COV2.S" (4 trials), "Galcanezumab" (4 trials) and "VLA15" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Rochester Clinical Research, Inc.


The vast majority of trials in "Rochester Clinical Research, Inc." are 146 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Rochester Clinical Research, Inc.


Currently, there are NaN active trials in "Rochester Clinical Research, Inc.". undefined are not yet recruiting, 10 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 126 completed trials in Rochester Clinical Research, Inc., undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Rochester Clinical Research, Inc., 11 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 86Phase 3: 86Phase 2: 59Phase 2: 59Phase 1: 11Phase 1: 11Not Applicable: 6Not Applicable: 6Phase 4: 5Phase 4: 5Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 126Completed: 126Active, not recruiting: 16Active, not recruiting: 16Recruiting: 10Recruiting: 10Terminated: 4Terminated: 4Unknown status: 3Unknown status: 3